05.01.2015 13:44:14
|
BioCryst Pharma Appoints Lynne Powell As Chief Commercial Officer - Quick Facts
(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) announced the appointment of Lynne Powell to the role of senior vice president and chief commercial officer, effective January 26, 2015. She brings 24 years of industry experience to BioCryst.
Most recently, Powell served as senior vice president of North American Commercial Operations at CSL Behring. Throughout her 17 year career at CSL Behring, she assumed increasing responsibilities within the R&D, and commercial functions of the organization.
Prior to CSL, she held positions of increasing responsibility within GlaxoWellcome's commercial strategy and clinical research organizations.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioCryst Pharmaceuticalsmehr Nachrichten
03.11.24 |
Ausblick: BioCryst Pharmaceuticals präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu BioCryst Pharmaceuticalsmehr Analysen
Aktien in diesem Artikel
BioCryst Pharmaceuticals | 8,60 | -0,02% |
|